Commercialization and Prototype Development
Elisa Kit Development – BioMark has successfully developed Elisa kits using antibodies generated at UBC’s
BioMark Diagnostics Inc., providing universal access to cancer diagnostics and early stage detection by leveraging the power of new technology.
BioMark Diagnostics is leading the world in early-stage cancer detection with an oncology focus designed to improve patient outcomes.
Elisa Kit Development – BioMark has successfully developed Elisa kits using antibodies generated at UBC’s
BioMark would like to introduce and welcome 2 new members to its scientific advisory board.
No paperwork, no hassle. We keep things digital, easy and regular.
*Zero Spam Policy. You will need to confirm your email address to receive our news to your inbox.
1 604 370 0779
130 3851 Shell Road
Richmond BC
Canada V6X 2W2
Rashid A. Bux (CEO)
[email protected]